189 related articles for article (PubMed ID: 2467933)
1. Carrier-induced epitopic suppression is initiated through clonal dominance.
Schutze MP; Deriaud E; Przewlocki G; LeClerc C
J Immunol; 1989 Apr; 142(8):2635-40. PubMed ID: 2467933
[TBL] [Abstract][Full Text] [Related]
2. The in vivo elimination of CD4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression.
Leclerc C; Schutze MP; Deriaud E; Przewlocki G
J Immunol; 1990 Sep; 145(5):1343-9. PubMed ID: 1696595
[TBL] [Abstract][Full Text] [Related]
3. Carrier-induced, hapten-specific suppression: a problem of antigen presentation?
Renjifo X; Wolf S; Pastoret PP; Bazin H; Urbain J; Leo O; Moser M
J Immunol; 1998 Jul; 161(2):702-6. PubMed ID: 9670945
[TBL] [Abstract][Full Text] [Related]
4. Bypass of carrier-induced epitope-specific suppression using a T-helper epitope.
Sad S; Rao K; Arora R; Talwar GP; Raghupathy R
Immunology; 1992 Aug; 76(4):599-603. PubMed ID: 1383134
[TBL] [Abstract][Full Text] [Related]
5. Carrier-induced suppression of the antibody response to a 'self' hapten.
Sad S; Gupta HM; Talwar GP; Raghupathy R
Immunology; 1991 Oct; 74(2):223-7. PubMed ID: 1748470
[TBL] [Abstract][Full Text] [Related]
6. Alloantigen pretreatment induces a down-regulation of the in vivo subsequent development of cytotoxic T lymphocytes directed against linked alloantigens.
Schutze MP; Langlade-Demoyen P; Przewlocki G; Leclerc C
Eur J Immunol; 1989 Aug; 19(8):1365-71. PubMed ID: 2789138
[TBL] [Abstract][Full Text] [Related]
7. Ocular immune responses. II. Priming of A/J mice in the vitreous induces either enhancement of or suppression of subsequent hapten-specific DTH responses.
Foster CS; Monroe JG; Campbell R; Kalpaxis J; Wetzig R; Greene MI
J Immunol; 1986 Apr; 136(8):2787-91. PubMed ID: 2420867
[TBL] [Abstract][Full Text] [Related]
8. Suppression of reaginic antibody formation. III. Relationship between immunogenecity and tolerogenicity of hapten-carrier conjugates.
Lee WY; Sehon AH
J Immunol; 1976 Jun; 116(6):1711-8. PubMed ID: 58048
[TBL] [Abstract][Full Text] [Related]
9. Epitopic suppression in synthetic vaccine models: analysis of the effector mechanisms.
Schutze MP; Leclerc C; Vogel FR; Chedid L
Cell Immunol; 1987 Jan; 104(1):79-90. PubMed ID: 2433056
[TBL] [Abstract][Full Text] [Related]
10. T cells specific to hapten carrier but not to carrier alone assist in the production of anti-hapten and anti-carrier antibodies.
Shimizu T; Osaka Y; Banri-Koike C; Yoshida M; Endo K; Furukawa K; Oda M; Murakami A; Ogawa S; Abe R; Azuma T
Int Immunol; 2007 Oct; 19(10):1157-64. PubMed ID: 17881502
[TBL] [Abstract][Full Text] [Related]
11. The specificity of in vivo tolerance to haptens in NZB and normal mice after exposure to hapten-modified syngeneic spleen cells.
Cowdery JS; Laskin CA; Steinberg AD
J Immunol; 1982 Apr; 128(4):1571-6. PubMed ID: 6174607
[TBL] [Abstract][Full Text] [Related]
12. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes.
Moser G; Burakoff SJ; Abbas AK
J Immunol; 1982 Jul; 129(1):63-9. PubMed ID: 6177761
[TBL] [Abstract][Full Text] [Related]
13. Tolerance induction during ontogeny. II. Distinct unresponsive states in immature mice question the generality of clonal abortion.
Waters CA; Diener E
Eur J Immunol; 1983 Nov; 13(11):928-35. PubMed ID: 6196209
[TBL] [Abstract][Full Text] [Related]
14. Role of self carriers in the immune response and tolerance. X. A lymphoid dendritic-like tumor, P388AD.2, acts as a novel immunogenic carrier for hapten.
Cogswell JP; Phipps RP; Scott DW
J Immunol; 1986 Aug; 137(3):777-83. PubMed ID: 3522737
[TBL] [Abstract][Full Text] [Related]
15. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
16. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
Good MF; Nossal GJ
J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
[TBL] [Abstract][Full Text] [Related]
17. Determinant specific suppression of antigen-induced T cell proliferation in the guinea pig. II. Determinant specific suppression of in vitro T cell responsiveness parallels a selective suppression of anti-hapten but not anti-carrier antibody responses.
Baskin BL; Blake JT; Rosenthal AS
J Immunol; 1980 Jan; 124(1):189-93. PubMed ID: 6153095
[TBL] [Abstract][Full Text] [Related]
18. Interaction in vivo between hapten-specific suppressor T cells and an in vitro cultured helper T cell line.
Owens T; Miller JF
J Immunol; 1987 Mar; 138(6):1687-92. PubMed ID: 2950167
[TBL] [Abstract][Full Text] [Related]
19. Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies.
Jegerlehner A; Wiesel M; Dietmeier K; Zabel F; Gatto D; Saudan P; Bachmann MF
Vaccine; 2010 Jul; 28(33):5503-12. PubMed ID: 20307591
[TBL] [Abstract][Full Text] [Related]
20. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
